KORU Medical Systems, Inc. Overview
Pro stress-test →KORU Medical Systems is a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH).
Strategic Profile
Pro stress-test →The Freedom System includes the Freedom60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™, and received its first FDA clearance in 1994. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process.
Competitive Landscape
Pro stress-test →KORU Medical operates in the specialized subcutaneous drug delivery market serving immunodeficiency and rare disease patients. The company competes indirectly with larger medical device manufacturers and specialty pharmaceutical distributors. Analyst consensus rates the company as "Moderate Buy", indicating investor confidence despite its small scale relative to larger peers.
Industry Context
KORU Medical Systems, Inc. operates in Medical Devices - Specialty Drug Delivery Systems.
Key facts
Founded: 1980 · Headquarters: Mahwah, New Jersey, United States · Revenue: $41.1M · Market cap: $219M